Dubai Health announced that its Genomic Medicine Centre (GMC) has earned accreditation from the College of American Pathologists (CAP), the globally-recognised authority in laboratory quality ...

A research team led by the Department of Pediatrics and Adolescent Medicine, School of Clinical Medicine, LKS Faculty of ...

This year saw notable progress in head and neck cancers, Huntington's disease, personalized genetic therapy, and heart ...

A newly developed AI can predict which diseases specific genetic mutations are likely to cause, not just whether they are ...

All-RNA, non-viral, LNP-based PRINT™ platform is designed to develop safer, durable, one-time therapies for a broad range of unmet needsAddition is advancing a robust pipeline of PRINTed therapeutics ...

Scientists at the Icahn School of Medicine at Mount Sinai have developed a novel artificial intelligence tool that not only ...

University of California spinout Addition Therapeutics has uncloaked, revealing “breakthrough” PRINT technology it hopes will fuel a new wave of genetic medicine. | University of California spinout ...

Mount Sinai scientists developed V2P, a powerful new AI tool that predicts how specific DNA mutations translate into disease, ...

A new class of life-saving drugs is helping children who once had no hope. But some carry a price tag of millions for a ...

A Mayo Clinic study reports that current genetic screening guidelines fall short in identifying the majority of individuals ...

Investigations suggest V2P may be efficiently applied for the automated identification of causal variants in simulated and actual patient sequencing data across phenotypes.

BGI Genomics successfully convened its 2025 European Partnership & Networking Summit on December 5th at the Budapest Marriott ...